Experimental mRNA cancer vaccine shows tumor-fighting promise in mouse study
Properly proved. Has structure, has flavour, has a point.
Summary
An experimental mRNA cancer vaccine developed by the University of Florida, published in Nature Biomedical Engineering, showed promising results in mice by boosting the immune system's response against tumors. When combined with immune checkpoint inhibitors (common anticancer drugs), the vaccine triggered a strong antitumor response, with some cases showing tumors completely wiped out by the vaccine alone. Unlike traditional cancer vaccines that target specific tumor proteins, this approach aims to create a universal "off-the-shelf" treatment that revs up the immune system as if fighting a virus.
Key quotes
· 3 pulledAn experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study
Pairing the test vaccine with common anticancer drugs called immune checkpoint inhibitors triggered a strong antitumor response
The results were dramatic—when paired with checkpoint inhibitors, tumors shrank, and in some cases, the vaccine alone wiped them out
You might also wanna read
Scientists Develop Universal Cancer Vaccine Using mRNA Technology
Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,
newatlas.com·10mo ago
Personalized mRNA Cancer Vaccine Shows 49% Risk Reduction at 5-Year Follow-up
Moderna and Merck report promising 5-year follow-up results for their personalized mRNA cancer vaccine combined with Keytruda immunotherapy.
arstechnica.com·4mo ago
Engineered immunotherapy drug eliminates aggressive metastatic cancers in clinical trial
Researchers at Rockefeller University have developed an engineered CD40 agonist antibody that successfully eliminated aggressive metastatic
rockefeller.edu·9mo ago
CRISPR-Engineered Fat Cells Show Promise for Starving Cancer Tumors
Researchers at UC San Francisco have developed a novel cancer treatment approach using CRISPR-engineered fat cells to starve tumors. They tr
ucsf.edu·5mo ago
Gemma-Based AI Model Identifies Potential Cancer Therapy Pathway Through Conditional Immune Amplification
Researchers used a new 27 billion parameter foundation model called C2S-Scale 27B, built on Google's Gemma family of open models, to discove
blog.google·7mo ago